Vascular plasticity in cerebrovascular disorders

Journal of Cerebral Blood Flow and Metabolism

Volumn 31, Issue 7, 2011, Pages 1554-1571

  Edvinsson, Lars I H ^a,b   Povlsen, Gro Klitgaard ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b LUND UNIVERSITY   (Sweden)

Author keywords

cerebral blood vessels; contractile receptors; ischemia; protein kinases; transcriptional regulation

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; 1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ANGIOTENSIN 1 RECEPTOR; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; ENDOTHELIN B RECEPTOR; G PROTEIN COUPLED RECEPTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C; SEROTONIN 1B RECEPTOR; SEROTONIN 1D RECEPTOR;

BLOOD VESSEL; BRAIN ARTERY; BRAIN ISCHEMIA; CELL DEATH; CEREBROVASCULAR DISEASE; CORONARY REPERFUSION; ENZYME ACTIVATION; HUMAN; INFLAMMATION; INTRACELLULAR SIGNALING; MICROVASCULATURE; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL; NEUROLOGIC DISEASE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE; SUBARACHNOID HEMORRHAGE; TISSUE CULTURE; VASCULAR PLASTICITY; VASOCONSTRICTION;

ANIMALS; BRAIN; CEREBRAL ARTERIES; HUMANS; SIGNAL TRANSDUCTION; STROKE; VASOCONSTRICTION;

EID: 79959831866     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2011.70     Document Type: Review

References (137)

1. Ahnstedt H, Säveland H, Nilsson O, Edvinsson L (2011) Human cerebrovascular contractile receptors are up-regulated via a B-Raf/MEK/ERK-sensitive signaling pathway. BMC Neurosci 12:5
2. Alessandrini A, Namura S, Moskowitz MA, Bonventre JV (1999) MEK1 protein kinase inhibition protects against damage resulting from focal cerebral ischemia. Proc Natl Acad Sci USA 96:12866-9 (Pubitemid 29513594)
3. Allen GS, Ahn HS, Preziosi TJ, Battye R, Boone SC, Chou SN, Kelly DL, Weir BK, Crabbe RA, Lavik PJ, Rosen-bloom SB, Dorsey FC, Ingram CR, Mellits DE, Bertsch LA, Boisvert DP, Hundley MB, Johnson RK, Strom JA, Transou CR (1983) Cerebral arterial spasm-a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med 308:619-24 (Pubitemid 13152325)
4. Ansar S, Edvinsson L (2008) Subtype activation and interaction of protein kinase C and mitogen-activated protein kinase controlling receptor expression in cerebral arteries and microvessels after subarachnoid hemorrhage. Stroke 39:185-90
5. Ansar S, Edvinsson L (2009) Equal contribution of increased intracranial pressure and subarachnoid blood to cerebral blood flow reduction and receptor upregula-tion after subarachnoid hemorrhage. Laboratory investigation. J Neurosurg 111:978-87
6. Ansar S, Larsen C, Maddahi A, Edvinsson L (2010) Subarachnoid hemorrhage induces enhanced expression of thromboxane A2 receptors in rat cerebral arteries. Brain Res 1316:163-72
7. Ansar S, Nilsson E, Nilsson O, Säveland H, Edvinsson L (2009) MAPK signalling pathway regulate cerebrovas-cular receptor expression in human cerebral arteries. J Cereb Blood Flow Metab 29:S495-6
8. Ansar S, Vikman P, Nielsen M, Edvinsson L (2008) Cerebrovascular ETB, 5-HT1B and AT1 receptor upre-gulation correlates with reduction in regional CBF after subarachnoid hemorrhage. Am J Physiol Heart Circ Physiol 294:H3750-8 (Pubitemid 350230923)
9. Asano T, Ikegaki I, Suzuki Y, Satoh S, Shibuya M (1989) Endothelin and the production of cerebral vasospasm in dogs. Biochem Biophys Res Commun 159: 1345-51 (Pubitemid 19101130)
10. Baek EB, Jin C, Park SJ, Park KS, Yoo HY, Jeon JH, Earm YE, Kim SJ (2010) Differential recruitment of mechanisms for myogenic responses according to luminal pressure and arterial types. Pflugers Arch 460:19-29
11. Beg SA, Hansen-Schwartz JA, Vikman PJ, Xu CB, Edvins-son LI (2006) ERK1/2 inhibition attenuates cerebral blood flow reduction and abolishes ET(B) and 5-HT(1B) receptor upregulation after subarachnoid hemorrhage in rat. J Cereb Blood Flow Metab 26:846-56
12. Beg SS, Hansen-Schwartz JA, Vikman PJ, Xu CB, Edvins-son LI (2007) Protein kinase C inhibition prevents upregulation of vascular ET(B) and 5-HT(1B) receptors and reverses cerebral blood flow reduction after sub-arachnoid haemorrhage in rats. J Cereb Blood Flow Metab 27:21-32 (Pubitemid 46006581)
13. Beltman J, McCormick F, Cook SJ (1996) The selective protein kinase C inhibitor, Ro-31-8220, inhibits mito-gen-activated protein kinase phosphatase-1 (MKP-1) expression, induces c-Jun expression, and activates Jun N-terminal kinase. J Biol Chem 271:27018-24 (Pubitemid 26359119)
14. Bhardwaj A, Wu Y, Hurn PD, Kirsch JR, Traystman RJ (2000) Administration of selective endothelin receptor type A antagonist Ro 61-1790 does not improve outcome in focal cerebral ischemia in cat. J Cereb Blood Flow Metab 20:499-504 (Pubitemid 30164894)
15. Bonfils PK, Reith J, Hasseldam H, Johansen FF (2006) Estimation of the hypothermic component in neuropro-tection provided by cannabinoids following cerebral ischemia. Neurochem Int 49:508-18 (Pubitemid 44189647)
16. Boulton TG, Nye SH, Robbins DJ, Ip NY, Radziejewska E, Morgenbesser SD, DePinho RA, Panayotatos N, Cobb MH, Yancopoulos GD (1991) ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 65:663-75
17. Brehm BR, Klaussner M, Wolf SC (2002) Chronic elevated endothelin-1 concentrations regulate mitogen-activated protein kinases ERK 1 and ERK 2 in vascular smooth muscle cells. Clin Sci 103:137S-40S (Pubitemid 35007138)
18. Bright R, Mochly-Rosen D (2005) The role of protein kinase C in cerebral ischemic and reperfusion injury. Stroke 36:2781-90
19. Bright R, Raval AP, Dembner JM, Perez-Pinzon MA, Steinberg GK, Yenari MA, Mochly-Rosen D (2004) Protein kinase C delta mediates cerebral reperfusion injury in vivo. J Neurosci 24:6880-8 (Pubitemid 39045444)
20. Chrysant SG (2007) The pathophysiologic role of the brain renin-angiotensin system in stroke protection: clinical implications. J Clin Hypertens (Greenwich) 9: 454-9
21. Chuquet J, Benchenane K, Toutain J, MacKenzie ET, Roussel S, Touzani O (2002) Selective blockade of endothelin-B receptors exacerbates ischemic brain damage in the rat. Stroke 33:3019-25 (Pubitemid 35462881)
22. Clark AR, Dean JL, Saklatvala J (2003) Post-transcriptional regulation of gene expression by mitogen-activated protein kinase p38. FEBS Lett 546:37-44 (Pubitemid 36782279)
23. Dawson DA, Sugano H, McCarron RM, Hallenbeck JM, Spatz M (1999) Endothelin receptor antagonist preserves microvascular perfusion and reduces ischemic brain damage following permanent focal ischemia. Neurochem Res 24:1499-505
24. Delgado TJ, Brismar J, Svendgaard NA (1985) Subarach-noid haemorrhage in the rat: angiography and fluorescence microscopy of the major cerebral arteries. Stroke 16:595-602 (Pubitemid 15007231)
25. Dorhout Mees SM, Rinkel GJ, Feigin VL, Algra A, Van den Bergh WM, Vermeulen M, Van Gijn J (2007) Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev CD000277
26. Dreier JP, Major S, Manning A, Woitzik J, Drenckhahn C, Steinbrink J, Tolias C, Oliveira-Ferreira AI, Fabricius M, Hartings JA, Vajkoczy P, Lauritzen M, Dirnagl U, Bohner G, Strong AJ (2009) Cortical spreading ischaemia is a novel process involved in ischaemic damage in patients with aneurysmal subarachnoid haemorrhage. Brain 132:1866-81
27. Dreier JP, Woitzik J, Fabricius M, Bhatia R, Major S, Drenckhahn C, Lehmann TN, Sarrafzadeh A, Willumsen L, Hartings JA, Sakowitz OW, Seemann JH, Thieme A, Lauritzen M, Strong AJ (2006) Delayed ischaemic neurological deficits after subarachnoid haemorrhage are associated with clusters of spreading depolarizations. Brain 129:3224-37 (Pubitemid 44871438)
28. Edvinsson L (2009) Cerebrovascular endothelin receptor upregulation in cerebral ischemia. Curr Vasc Pharmacol 7:26-33
29. Eichholtz T, de Bont DB, de Widt J, Liskamp RM, Ploegh HL (1993) A myristoylated pseudosubstrate peptide, a novel protein kinase C inhibitor. J Biol Chem 268: 1982-6 (Pubitemid 23033603)
30. Endres M, Engelhardt B, Koistinaho J, Lindvall O, Meairs S, Mohr JP, Planas A, Rothwell N, Schwaninger M, Schwab ME, Vivien D, Wieloch T, Dirnagl U (2008) Improving outcome after stroke: overcoming the transla-tional roadblock. Cerebrovasc Dis 25:268-78 (Pubitemid 351450431)
31. Engelhorn T, Goerike S, Doerfler A, Okorn C, Forsting M, Heusch G, Schulz R (2004) The angiotensin II type 1-receptor blocker candesartan increases cerebral blood flow, reduces infarct size, and improves neurologic outcome after transient cerebral ischemia in rats. J Cereb Blood Flow Metab 24:467-74 (Pubitemid 38455442)
32. Espinosa F, Weir B, Overton T, Castor W, Grace M, Boisvert D (1984) A randomized placebo-controlled double-blind trial of nimodipine after SAH in monkeys. Part 1: clinical and radiological findings. J Neurosurg 60: 1167-75 (Pubitemid 14108236)
33. Evans NJ, Walker JW (2008) Endothelin receptor dimers evaluated by FRET, ligand binding, and calcium mobilization. Biophys J 95:483-92
34. Feigin VL, Rinkel GJ, Algra A, Vermeulen M, Van Gijn J (1998) Calcium antagonists in patients with aneurysmal subarachnoid hemorrhage: a systematic review. Neurology 50:876-83 (Pubitemid 28212809)
35. Ginnan R, Guikema RJ, Singer HA, Jourd'heuil D (2006) PKC-d mediates activation of ERK1/2 and induction of iNOS by IL-1b in vascular smooth muscle cells. Am J Physiol Cell Physiol 290:C1583-91 (Pubitemid 43830798)
36. Grethe S, Ares MP, Andersson T, Porn-Ares MI (2004) p38 MAPK mediates TNF-induced apoptosis in endothelial cells via phosphorylation and downregulation of Bcl-x(L). Exp Cell Res 298:632-42 (Pubitemid 38950878)
37. Hansen-Schwartz J, Edvinsson L (2000) Increased sensitivity to ET-1 in rat cerebral arteries following organ culture. Neuroreport 11:649-52 (Pubitemid 30120492)
38. Hansen-Schwartz J, Hoel NL, Xu CB, Svendgaard NA, Edvinsson L (2003a) Subarachnoid hemorrhage-induced upregulation of the 5-HT1B receptor in cerebral arteries in rats. J Neurosurg 99:115-20 (Pubitemid 36753884)
39. Hansen-Schwartz J, Hoel NL, Zhou M, Xu CB, Svendgaard NA, Edvinsson L (2003b) Subarachnoid hemorrhage enhances endothelin receptor expression and function in rat cerebral arteries. Neurosurgery 52:1188-94
40. Hansen-Schwartz J, Nordstrom CH, Edvinsson L (2002a) Human endothelin subtype A receptor enhancement during tissue culture via de novo transcription. Neuro-surgery 50:127-33; discussion 33-35 (Pubitemid 41672562)
41. Hansen-Schwartz J, Svensson CL, Xu CB, Edvinsson L (2002b) Protein kinase mediated upregulation of endo-thelin A, endothelin B and 5-hydroxytryptamine 1B/1D receptors during organ culture in rat basilar artery. Br J Pharmacol 137:118-26 (Pubitemid 34983470)
42. Hansen-Schwartz J, Szok D, Edvinsson L (2002c) Expression of ET(A) and ET(B) receptor mRNA in human cerebral arteries. Br J Neurosurg 16:149-53 (Pubitemid 34539018)
43. Hansen-Schwartz J, Vajkoczy P, Macdonald RL, Pluta RM, Zhang JH (2007) Cerebral vasospasm: looking beyond vasoconstriction. Trends Pharmacol Sci 28:252-6 (Pubitemid 46818461)
44. Harada N, Himeno A, Shigematsu K, Sumikawa K, Niwa M (2002) Endothelin-1 binding to endothelin receptors in the rat anterior pituitary gland: possible formation of an ETA-ETB receptor heterodimer. Cell Mol Neurobiol 22:207-26
45. Henriksson M, Stenman E, Edvinsson L (2003) Intracellular pathways involved in upregulation of vascular endothe-lin type B receptors in cerebral arteries of the rat. Stroke 34:1479-83 (Pubitemid 36693521)
46. Henriksson M, Stenman E, Vikman P, Edvinsson L (2007a) MEK1/2 inhibition attenuates vascular ETA and ETB receptor alterations after cerebral ischaemia. Exp Brain Res 178:470-6 (Pubitemid 46569887)
47. Henriksson M, Stenman E, Vikman P, Edvinsson L (2007b) Protein kinase C inhibition attenuates vascular ETB receptor upregulation and decreases brain damage after cerebral ischemia in rat. BMC Neurosci 8:7
48. Henriksson M, Vikman P, Stenman E, Beg S, Edvinsson L (2006) Inhibition of PKC activity blocks the increase of ETB receptor expression in cerebral arteries. BMC Pharmacol 6:13
49. Henriksson M, Xu CB, Edvinsson L (2004) Importance of ERK1/2 in upregulation of endothelin type B receptors in cerebral arteries. Br J Pharmacol 142:1155-61 (Pubitemid 39093012)
50. Hijdra A, Braakman R, Van Gijn J, Vermeulen M, Van Crevel H (1987) Aneurysmal subarachnoid hemorrhage. Complications and outcome in a hospital population. Stroke 18:1061-7 (Pubitemid 18014473)
51. Hoel NL, Hansen-Schwartz J, Edvinsson L (2001) Selective up-regulation of 5-HT(1B/1D) receptors during organ culture of cerebral arteries. Neuroreport 12:1605-8 (Pubitemid 32521472)
52. Hosomi N, Mizushige K, Kitadai M, Ohyama H, Ichihara SI, Takahashi T, Matsuo H (1999) Induced hypertension treatment to improve cerebral ischemic injury after transient forebrain ischemia. Brain Res 835:188-96 (Pubitemid 29343780)
53. Hosomi N, Nishiyama A, Ban CR, Naya T, Takahashi T, Kohno M, Koziol JA (2005) Angiotensin type 1 receptor blockage improves ischemic injury following transient focal cerebral ischemia. Neuroscience 134:225-31 (Pubitemid 40943649)
54. Hossmann KA (2009) Pathophysiological basis of transla-tional stroke research. Folia Neuropathol 47:213-27
55. Hsieh MH, Nguyen HT (2005) Molecular mechanism of apoptosis induced by mechanical forces. Int Rev Cytol 245:45-90
56. Huang J, Upadhyay UM, Tamargo RJ (2006) Inflammation in stroke and focal cerebral ischemia. Surg Neurol 66:232-45 (Pubitemid 44279808)
57. Iadecola C (2009) Bleeding in the brain: killer waves of depolarization in subarachnoid bleed. Nat Med 15: 1131-2
58. Jamali R, Edvinsson L (2006) Involvement of protein kinases on the upregulation of endothelin receptors in rat basilar and mesenteric arteries. Exp Biol Med (Maywood) 231:403-11
59. Johansson SE, Povlsen GK, Edvinsson L (2011) Expres-sional changes in cerebrovascular receptors after global cerebral ischemia. J Cereb Blood Flow Metab 31
60. Karin M (2005) Inflammation-activated protein kinases as targets for drug development. Proc Am Thorac Soc 2:386-90; discussion 94-95 (Pubitemid 41699701)
61. Kim HR, Appel S, Vetterkind S, Gangopadhyay SS, Morgan KG (2008) Smooth muscle signalling pathways in health and disease. J Cell Mol Med 12:2165-80
62. Konczalla J, Vatter H, Weidauer S, Raabe A, Seifert V (2006) Alteration of the cerebrovascular function of endothelin B receptor after subarachnoidal hemorrhage in the rat. Exp Biol Med (Maywood) 231:1064-8 (Pubitemid 43845579)
63. Kristiansen KA, Klitgaard Povlsen G, Hansen-Schwartz J, Edvinsson L, Johansen FF (2011) The time course for expression of vascular endothelin ETB receptors after experimental stroke in rat. J Cereb Blood Flow Metab 31
64. Kumar S, Boehm J, Lee JC (2003) p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nat Rev Drug Discov 2:717-26 (Pubitemid 37361787)
65. Laher I, Zhang JH (2001) Protein kinase C and cerebral vasospasm. J Cereb Blood Flow Metab 21:887-906 (Pubitemid 32729825)
66. Lampl Y, Fleminger G, Gilad R, Galron R, Sarova-Pinhas I, Sokolovsky M (1997) Endothelin in cerebrospinal fluid and plasma of patients in the early stage of ischemic stroke. Stroke 28:1951-5 (Pubitemid 27459002)
67. Larsen CC, Povlsen GK, Rasmussen MN, Edvinsson L (2010) Improvement in neurological outcome and abolition of cerebrovascular endothelin B and 5-hydro-xytryptamine 1B receptor upregulation through mito-gen-activated protein kinase kinase 1/2 inhibition after subarachnoid hemorrhage in rats. J Neurosurg 114: 1143-53
68. Lees KR, Zivin JA, Ashwood T, Davalos A, Davis SM, Diener HC, Grotta J, Lyden P, Shuaib A, Hardemark HG, Wasiewski WW (2006) NXY-059 for acute ischemic stroke. N Engl J Med 354:588-600 (Pubitemid 43209106)
69. Lennmyr F, Karlsson S, Gerwins P, Ata KA, Terent A (2002) Activation of mitogen-activated protein kinases in experimental cerebral ischemia. Acta Neurol Scand 106: 333-40 (Pubitemid 36020739)
70. Leseth KH, Adner M, Berg HK, White LR, Aasly J, Edvinsson L (1999) Cytokines increase endothelin ETB receptor contractile activity in rat cerebral artery. Neuroreport 10:2355-9 (Pubitemid 29367938)
71. Li J, Culman J, Hortnagl H, Zhao Y, Gerova N, Timm M, Blume A, Zimmermann M, Seidel K, Dirnagl U, Unger T (2005) Angiotensin AT2 receptor protects against cerebral ischemia-induced neuronal injury. FASEB J 19: 617-9 (Pubitemid 40471263)
72. Li XS, Wang QD, Pernow J (1995) Beneficial effects of the endothelin receptor antagonist bosentan on myocardial and endothelial injury following ischaemia/reperfusion in the rat. Eur J Pharmacol 283:161-8
73. Lindstedt I, Xu CB, Zhang Y, Edvinsson L (2009) Increased perfusion pressure enhances the expression of endothe-lin (ETB) and angiotensin II (AT1, AT2) receptors in rat mesenteric artery smooth muscle cells. Blood Press 18:78-85
74. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, Ford E, Furie K, Go A, Green-lund K, Haase N, Hailpern S, Ho M, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott M, Meigs J, Mozaffarian D, Nichol G, O'Donnell C, Roger V, Rosamond W, Sacco R, Sorlie P, Stafford R, Steinberger J, Thom T, Wasserthiel-Smoller S, Wong N, Wylie-Rosett J, Hong Y (2009) Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119:480-6
75. Lou M, Blume A, Zhao Y, Gohlke P, Deuschl G, Herdegen T, Culman J (2004) Sustained blockade of brain AT1 receptors before and after focal cerebral ischemia alleviates neurologic deficits and reduces neuronal injury, apoptosis, and inflammatory responses in the rat. J Cereb Blood Flow Metab 24:536-47 (Pubitemid 38608286)
76. Macdonald RL, Kassell NF, Mayer S, Ruefenacht D, Schmiedek P, Weidauer S, Frey A, Roux S, Pasqualin A (2008a) Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke 39: 3015-21
77. Macdonald RL, Kassell NF, Mayer S, Ruefenacht D, Schmiedek P, Weidauer S, Frey A, Roux S, Pasqualin A, on behalf of the CONSCIOUS-1 Investigators (2008b) Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke 39: 3015-21
78. Macrae IM, Robinson MJ, Graham DI, Reid JL, McCulloch J (1993) Endothelin-1-induced reductions in cerebral blood flow: dose dependency, time course, and neuro-pathological consequences. J Cereb Blood Flow Metab 13:276-84 (Pubitemid 23067462)
79. Maddahi A, Ansar S, Chen Q, Edvinsson L (2011) Blockade of the MEK/ERK pathway with a raf inhibitor prevents activation of pro-inflammatory mediators in cerebral arteries and reduction in cerebral blood flow after subarachnoid hemorrhage in a rat model. J Cereb Blood Flow Metab 31:144-54
80. Maddahi A, Chen Q, Edvinsson L (2009) Enhanced cerebrovascular expression of matrix metalloprotei-nase-9 and tissue inhibitor of metalloproteinase-1 via the MEK/ERK pathway during cerebral ischemia in the rat. BMC Neurosci 10:56
81. Maddahi A, Edvinsson L (2008) Enhanced expressions of microvascular smooth muscle receptors after focal cerebral ischemia occur via the MAPK MEK/ERK pathway. BMC Neurosci 9:85
82. Maddahi A, Edvinsson L (2010) Cerebral ischemia induces microvascular pro-inflammatory cytokine expression via the MEK/ERK pathway. J Neuroinflamma-tion 7:14
83. Masaki T (1995) Possible role of endothelin in endothelial regulation of vascular tone. Annu Rev Pharmacol Toxicol 35:235-55
84. McAuley MA, Breu V, Graham DI, McCulloch J (1996) The effects of bosentan on cerebral blood flow and histopathology following middle cerebral artery occlusion in the rat. Eur J Pharmacol 307:171-81 (Pubitemid 26226221)
85. McCulloch J, Dewar D (2001) A radical approach to stroke therapy. Proc Natl Acad Sci USA 98:10989-91 (Pubitemid 32928671)
86. Memezawa H, Minamisawa H, Smith ML, Siesjo BK (1992a) Ischemic penumbra in a model of reversible middle cerebral artery occlusion in the rat. Exp Brain Res 89:67-78
87. Memezawa H, Smith ML, Siesjo BK (1992b) Penumbral tissues salvaged by reperfusion following middle cerebral artery occlusion in rats. Stroke 23:552-9
88. Mitsios N, Gaffney J, Kumar P, Krupinski J, Kumar S, Slevin M (2006) Pathophysiology of acute ischaemic stroke: an analysis of common signalling mechanisms and identification of new molecular targets. Pathobiology 73:159-75 (Pubitemid 44808076)
89. Nakayama K, Tanaka Y (1993) Stretch-induced contraction and Ca2+ mobilization in vascular smooth muscle. Biol Signals 2:241-52 (Pubitemid 24101782)
90. Namura S, Iihara K, Takami S, Nagata I, Kikuchi H, Matsushita K, Moskowitz MA, Bonventre JV, Alessan-drini A (2001) Intravenous administration of MEK inhibitor U0126 affords brain protection against fore-brain ischemia and focal cerebral ischemia. Proc Natl Acad Sci USA 98:11569-74 (Pubitemid 32928769)
91. Neuschmelting V, Marbacher S, Fathi AR, Jakob SM, Fandino J (2009) Elevated level of endothelin-1 in cerebrospinal fluid and lack of nitric oxide in basilar arterial plasma associated with cerebral vasospasm after subarachnoid haemorrhage in rabbits. Acta Neurochir (Wien) 151:795-801; discussion 801-802
92. Nilsson D, Wackenfors A, Gustafsson L, Edvinsson L, Paulsson P, Ingemansson R, Malmsjo M (2008) Increased ET(A) and ET(B) receptor contraction in the left internal mammary artery from patients with hypertension. J Hum Hypertens 22:226-9 (Pubitemid 351266495)
93. Nilsson T, Cantera L, Adner M, Edvinsson L (1997) Presence of contractile endothelin-A and dilatory endothelin-B receptors in human cerebral arteries. Neurosurgery 40:346-51; discussion 51-53
94. Nilsson T, Longmore J, Shaw D, Olesen IJ, Edvinsson L (1999) Contractile 5-HT1B receptors in human cerebral arteries: Pharmacological characterization and localization with immunocytochemistry. Br J Pharmacol 128: 1133-40
95. O'Collins VE, Macleod MR, Donnan GA, Horky LL, Van der Worp BH, Howells DW (2006) 1,026 experimental treatments in acute stroke. Ann Neurol 59:467-77 (Pubitemid 43358067)
96. Olesen S-P, Clapham DE, Davies PF (1988) Haemodynamic shear stress activates a K+ current in vascular endothe-lial cells. Nature 331:168-70 (Pubitemid 18042148)
97. Patel TR, Galbraith S, Graham DI, Hallak H, Doherty AM, McCulloch J (1996) Endothelin receptor antagonist increases cerebral perfusion and reduces ischaemic damage in feline focal cerebral ischaemia. J Cereb Blood Flow Metab 16:950-8 (Pubitemid 26292062)
98. Patel TR, McCulloch J (1996) Failure of an endothelin antagonist to modify hypoperfusion after transient global ischaemia in the rat. J Cereb Blood Flow Metab 16:490-9 (Pubitemid 26125337)
99. Pluta RM, Hansen-Schwartz J, Dreier J, Vajkoczy P, Macdonald RL, Nishizawa S, Kasuya H, Wellman G, Keller E, Zauner A, Dorsch N, Clark J, Ono S, Kiris T, Leroux P, Zhang JH (2009) Cerebral vasospasm following subarachnoid hemorrhage: time for a new world of thought. Neurol Res 31:151-8
100. Prunell GF, Mathiesen T, Svendgaard NA (2002) A new experimental model in rats for study of the patho-physiology of subarachnoid hemorrhage. Neuroreport 13:2553-6 (Pubitemid 36143561)
101. Rasmussen MN, Hornbak M, Sheykhzade M, Edvinsson L (2011) Enhanced expression of endothlin ETB, angiotensin AT1, 5-hydroxytryptamine 5-HT1B receptors in the middle cerebral artery distal to a permanent occlusion in rat. J Cereb Blood Flow Metab 31
102. Robinson MJ, Macrae IM, Todd M, Reid JL, McCulloch J (1990) Reduction of local cerebral blood flow to pathological levels by endothelin-1 applied to the middle cerebral artery in the rat. Neurosci Lett 118: 269-72 (Pubitemid 20334893)
103. Roman RJ, Renic M, Dunn KM, Takeuchi K, Hacein-Bey L (2006) Evidence that 20-HETE contributes to the development of acute and delayed cerebral vasospasm. Neurol Res 28:738-49 (Pubitemid 44656100)
104. Saklatvala J, Dean J, Clark A (2003) Control of the expression of inflammatory response genes. Biochem Soc Symp 70:95-106 (Pubitemid 38497218)
105. Sandhu H, Ansar S, Edvinsson L (2010a) Comparison of MEK/ERK pathway inhibitors on the upregulation of vascular G-protein coupled receptors in rat cerebral arteries. Eur J Pharmacol 644:128-37
106. Sandhu H, Xu CB, Edvinsson L (2010b) Upregulation of contractile endothelin type B receptors by lipid-soluble cigarette smoking particles in rat cerebral arteries via activation of MAPK. Toxicol Appl Pharmacol 249:25-32
107. Sarrafzadeh A, Schlenk F, Gericke C, Vajkoczy P (2011) Relevance of cerebral interleukin-6 after aneurysmal subarachnoid hemorrhage. Neurocrit Care 13:339-46
108. Schrader J, Luders S, Kulschewski A, Berger J, Zidek W, Treib J, Einhaupl K, Diener HC, Dominiak P (2003) The ACCESS Study: evaluation of Acute Candesartan Cilex-etil Therapy in Stroke Survivors. Stroke 34:1699-703 (Pubitemid 36842630)
109. Schubert GA, Schilling L, Thome C (2008) Clazosentan, an endothelin receptor antagonist, prevents early hypoper-fusion during the acute phase of massive experimental subarachnoid hemorrhage: a laser Doppler flowmetry study in rats. J Neurosurg 109:1134-40
110. Shobha N, Buchan AM, Hill MD (2011) Thrombolysis at 3-4.5 hours after acute ischemic stroke onset-evidence from the Canadian Alteplase for Stroke Effectiveness Study (CASES) registry. Cerebrovasc Dis 31:223-8
111. Siesjo BK, Katsura K, Zhao Q, Folbergrova J, Pahlmark K, Siesjo P, Smith ML (1995) Mechanisms of secondary brain damage in global and focal ischemia: a speculative synthesis. J Neurotrauma 12:943-56
112. Slevin M, Krupinski J, Slowik A, Rubio F, Szczudlik A, Gaffney J (2000) Activation of MAP kinase (ERK-/ ERK-2), tyrosine kinase and VEGF in the human brain following acute ischaemic stroke. Neuroreport 11:2759-64
113. Smith ML, Bendek G, Dahlgren N, Rosen I, Wieloch T, Siesjo BK (1984) Models for studying long-term recovery following forebrain ischemia in the rat. 2. A 2-vessel occlusion model. Acta Neurol Scand 69: 385-401 (Pubitemid 14080982)
114. Standaert ML, Bandyopadhyay G, Antwi EK, Farese RV (1999) RO 31-8220 activates c-Jun N-terminal kinase and glycogen synthase in rat adipocytes and L6 myotubes. Comparison to actions of insulin. Endocrinology 140:2145-51 (Pubitemid 30636453)
115. Stemer A, Lyden P (2011) Evolution of the thrombolytic treatment window for acute ischemic stroke. Curr Neurol Neurosci Rep 10:29-33
116. Stenman E, Edvinsson L (2004) Cerebral ischemia enhances vascular angiotensin AT1 receptor-mediated contraction in rats. Stroke 35:970-4 (Pubitemid 38419812)
117. Stenman E, Jamali R, Henriksson M, Maddahi A, Edvins-son L (2007) Cooperative effect of angiotensin AT(1) and endothelin ET(A) receptor antagonism limits the brain damage after ischemic stroke in rat. Eur J Pharmacol 570:142-8 (Pubitemid 47248667)
118. Stenman E, Malmsjo M, Uddman E, Gido G, Wieloch T, Edvinsson L (2002) Cerebral ischemia upregulates vascular endothelin ET(B) receptors in rat. Stroke 33:2311-6 (Pubitemid 35014648)
119. Sugawara T, Kinouchi H, Oda M, Shoji H, Omae T, Mizoi K (2005) Candesartan reduces superoxide production after global cerebral ischemia. Neuroreport 16:325-8 (Pubitemid 40434559)
120. Szok D, Hansen-Schwartz J, Edvinsson L (2001) In depth pharmacological characterization of endothelin B receptors in the rat middle cerebral artery. Neurosci Lett 314:69-72 (Pubitemid 33043807)
121. Tamura A, Graham DI, McCulloch J, Teasdale GM (1981a) Focal cerebral ischaemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J Cereb Blood Flow Metab 1:53-60 (Pubitemid 12230166)
122. Tamura A, Graham DI, McCulloch J, Teasdale GM (1981b) Focal cerebral ischaemia in the rat: 2. Regional cerebral blood flow determined by [14C]iodoantipyrine auto-radiography following middle cerebral artery occlusion. J Cereb Blood Flow Metab 1:61-9 (Pubitemid 11026198)
123. Thampatty BP, Sherwood PR, Gallek MJ, Crago EA, Ren D, Hricik AJ, Kuo CW, Klamerus MM, Alexander SA, Bender CM, Hoffman LA, Horowitz MB, Kassam AB, Poloyac SM (2011) Role of endothelin-1 in human aneurysmal subarachnoid hemorrhage: associations with vasospasm and delayed cerebral ischemia. Neurocrit Care; 1 February 2011 (e-pub ahead of print)
124. Uddman E, Moller S, Adner M, Edvinsson L (1999) Cytokines induce increased endothelin ET(B) receptor-mediated contraction. Eur J Pharmacol 376:223-32 (Pubitemid 29320146)
125. Umemura K, Ishiye M, Kosuge K, Nakashima M (1995) Effect of combination of a tissue-type plasminogen activator and an endothelin receptor antagonist, FR139317, in the rat cerebral infarction model. Eur J Pharmacol 275:17-21
126. Uski T, Andersson KE, Brandt L, Edvinsson L, Ljunggren B (1983) Responses of isolated feline and human cerebral arteries to prostacyclin and some of its metabolites. J Cereb Blood Flow Metab 3:238-45 (Pubitemid 13025509)
127. Waldsee R, Ahnstedt H, Eftekhari S, Edvinsson L (2010) Involvement of calcium-calmodulin-dependent protein kinase II in endothelin receptor expression in rat cerebral arteries. Am J Physiol Heart Circ Physiol 298: H823-32
128. Warlow C, Sudlow C, Dennis M, Wardlaw J, Sandercock P (2003) Stroke. Lancet 362:1211-24 (Pubitemid 37255350)
129. Vatter H, Konczalla J, Weidauer S, Preibisch C, Raabe A, Zimmermann M, Seifert V (2007a) Characterization of the endothelin-B receptor expression and vasomotor function during experimental cerebral vasospasm. Neurosurgery 60:1100-8; discussion 8-9 (Pubitemid 46849859)
130. Vatter H, Konczalla J, Weidauer S, Preibisch C, Zimmer-mann M, Raabe A, Seifert V (2007b) Effect of delayed cerebral vasospasm on cerebrovascular endothelin A receptor expression and function. J Neurosurg 107: 121-7 (Pubitemid 47026479)
131. Vikman P, Edvinsson L (2006) Gene expression profiling in the human middle cerebral artery after cerebral ischemia. Eur J Neurol 13:1324-32 (Pubitemid 44736642)
132. Viossat I, Duverger D, Chapelat M, Pirotzky E, Chabrier PE, Braquet P (1993) Elevated tissue endothelin content during focal cerebral ischemia in the rat. J Cardiovasc Pharmacol 22(Suppl 8):S306-9
133. Waxham MN, Grotta JC, Silva AJ, Strong R, Aronowski J (1996) Ischemia-induced neuronal damage: a role for calcium/calmodulin-dependent protein kinase II. J Cereb Blood Flow Metab 16:1-6 (Pubitemid 26007946)
134. Wieloch T, Cardell M, Bingren H, Zivin J, Saitoh T (1991) Changes in the activity of protein kinase C and the differential subcellular redistribution of its isozymes in the rat striatum during and following transient forebrain ischemia. J Neurochem 56:1227-35 (Pubitemid 21902040)
135. Wilkins RH (1990) Cerebral vasospasm. Crit Rev Neurobiol 6:51-77 (Pubitemid 20320179)
136. Xu CB, Sun Y, Edvinsson L (2010) Cardiovascular risk factors regulate the expression of vascular endothelin receptors. Pharmacol Ther 127:148-55
137. Xu CB, Zheng JP, Zhang W, Zhang Y, Edvinsson L (2008) Lipid soluble smoke particles up-regulate vascular smooth muscle ETB receptors via activation of mitogen activating protein kinases and NF-kappaB pathways. Toxicol Sci 106:546-55